Antisense oligonucleotides: Is the glass half full or half empty?
10.1016/s0006-2952(97)00214-1
Crossref journal-article
Elsevier BV
Biochemical Pharmacology (78)
Bibliography

Bennett, C. F. (1998). Antisense oligonucleotides: Is the glass half full or half empty? Biochemical Pharmacology, 55(1), 9–19.

Authors 1
  1. C.Frank Bennett (first)
References 123 Referenced 89
  1. 10.1146/annurev.pa.32.040192.001553 / Annu Rev Pharmacol Toxicol / Therapeutic applications of oligonucleotides by Crooke (1992)
  2. 10.1126/science.8351515 / Science / Antisense oligonucleotides as therapeutic agents-Is the bullet really magical? by Stein (1993)
  3. 10.1146/annurev.pa.36.040196.000543 / Annu Rev Pharmacol Toxicol / Progress in antisense oligonucleotide therapeutics by Crooke (1996)
  4. 10.1002/bies.950171210 / Bioessays / The therapeutic potential of antisense oligonucleotides by Sharma (1995)
  5. 10.1089/ard.1994.4.67 / Antisense Res Dev / Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides by Stein (1994)
  6. 10.1038/nm1195-1119 / Nature Med / Does antisense exist? by Stein (1995)
  7. 10.1126/science.165.3898.1137 / Science / Interferon induction increased through chemical modification of synthetic polyribonucleotide by De Clercq (1969)
  8. 10.1021/bi00769a002 / Biochemistry / Stereochemistry of the transesterification step of ribonuclease T1 by Eckstein (1972)
  9. 10.1021/ja01040a043 / J Am Chem Soc / Protecting groups for nucleosides used in synthesizing oligonucleotides by Letsinger (1969)
  10. 10.1021/bi00590a017 / Biochemistry / Nonionic nucleic acid analogues. Synthesis and characterization of dideoxyribonucleoside methylphosphonates by Miller (1979)
  11. {'key': '10.1016/S0006-2952(97)00214-1_BIB11', 'first-page': '1537', 'article-title': 'Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3′ end of 16S rRNA', 'volume': '78', 'author': 'Jayaraman', 'year': '1981'} / Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3′ end of 16S rRNA by Jayaraman (1981)
  12. 10.1016/0006-291X(89)91719-1 / Biochem Biophys Res Commun / Comparative activity of α- and β-anomeric oligonucleotides on rabbit β globin synthesis: Inhibitory effect of cap targeted α-oligonucleotides by Bertrand (1989)
  13. 10.1126/science.7681216 / Science / Phosphorodithioate DNA as a potential therapeutic drug by Marshall (1993)
  14. {'key': '10.1016/S0006-2952(97)00214-1_BIB14', 'first-page': '7747', 'article-title': '2′-O-Alkyl oligoribonucleotides as antisense probes', 'volume': '87', 'author': 'Iribarren', 'year': '1990'} / 2′-O-Alkyl oligoribonucleotides as antisense probes by Iribarren (1990)
  15. 10.2533/chimia.1996.168 / Chimia / Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals by Altmann (1996)
  16. 10.1093/nar/23.11.2019 / Nucleic Acids Res / Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity by Cummins (1995)
  17. 10.1093/nar/24.3.411 / Nucleic Acid Res / Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-α by the incorporation of 2′-O-propyl modifications by McKay (1996)
  18. 10.1089/ard.1995.5.3 / Antisense Res Dev / (2′-5′)-Oligo-3′-deoxynucleotides: Selective binding to single-stranded RNA but not DNA by Alul (1995)
  19. 10.1016/S0960-894X(00)80412-6 / Bioorg Med Chem Lett / Synthesis and incorporation of methyleneoxyl (methylimino) linked thymidine dimer into antisense oligonucleotides by Debart (1992)
  20. 10.1021/ja00020a052 / J Am Chem Soc / Deoxyoligonucleotides bearing neutral analogues of phosphodiester linkages recognize duplex DNA via triple-helix formation by Matteucci (1991)
  21. {'key': '10.1016/S0006-2952(97)00214-1_BIB21', 'first-page': '5798', 'article-title': 'Oligonucleotide N3′ → P5′ phosphoramidates', 'volume': '92', 'author': 'Gryaznov', 'year': '1995'} / Oligonucleotide N3′ → P5′ phosphoramidates by Gryaznov (1995)
  22. {'key': '10.1016/S0006-2952(97)00214-1_BIB22', 'series-title': 'Carbohydrate Modifications in Antisense Research', 'first-page': '24', 'article-title': 'Novel backbone replacements for oligonucleotides', 'author': 'De Mesmaeker', 'year': '1994'} / Carbohydrate Modifications in Antisense Research / Novel backbone replacements for oligonucleotides by De Mesmaeker (1994)
  23. 10.1126/science.1962210 / Science / Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide by Nielsen (1991)
  24. 10.1016/S0021-9258(17)34023-1 / J Biol Chem / Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters by Dean (1994)
  25. 10.1074/jbc.271.24.14533 / J Biol Chem / Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras by Monia (1996)
  26. {'key': '10.1016/S0006-2952(97)00214-1_BIB26', 'first-page': '923', 'article-title': 'Pharmacokinetic properties of several novel oligonucleotide analogs in mice', 'volume': '277', 'author': 'Crooke', 'year': '1996', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / Pharmacokinetic properties of several novel oligonucleotide analogs in mice by Crooke (1996)
  27. 10.1016/0006-2952(95)00010-W / Biochem Pharmacol / Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1 by Zhang (1995)
  28. {'key': '10.1016/S0006-2952(97)00214-1_BIB28', 'first-page': '1181', 'article-title': 'Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats', 'volume': '267', 'author': 'Cossum', 'year': '1993', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats by Cossum (1993)
  29. 10.1016/0006-2952(95)00159-W / Biochem Pharmacol / In vivo stability, disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in rats by Zhang (1995)
  30. {'key': '10.1016/S0006-2952(97)00214-1_BIB30', 'first-page': '971', 'article-title': 'Pharmacokinetics and tissue distribution of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration', 'volume': '278', 'author': 'Zhang', 'year': '1996', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / Pharmacokinetics and tissue distribution of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration by Zhang (1996)
  31. {'key': '10.1016/S0006-2952(97)00214-1_BIB31', 'first-page': '7595', 'article-title': 'Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice', 'volume': '88', 'author': 'Agrawal', 'year': '1991'} / Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice by Agrawal (1991)
  32. {'key': '10.1016/S0006-2952(97)00214-1_BIB32', 'first-page': '89', 'article-title': 'Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats', 'volume': '269', 'author': 'Cossum', 'year': '1994', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats by Cossum (1994)
  33. {'key': '10.1016/S0006-2952(97)00214-1_BIB33', 'first-page': '932', 'article-title': 'Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate', 'volume': '45', 'author': 'Sands', 'year': '1994', 'journal-title': 'Mol Pharmacol'} / Mol Pharmacol / Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate by Sands (1994)
  34. 10.1002/jcla.1860090210 / J Clin Lab Anal / Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides by Srinivasan (1995)
  35. {'key': '10.1016/S0006-2952(97)00214-1_BIB35', 'first-page': '124', 'article-title': 'Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice', 'volume': '147', 'author': 'Plenat', 'year': '1995', 'journal-title': 'Am J Pathol'} / Am J Pathol / Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice by Plenat (1995)
  36. {'key': '10.1016/S0006-2952(97)00214-1_BIB36', 'first-page': '717', 'article-title': 'Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice', 'volume': '149', 'author': 'Rifai', 'year': '1996', 'journal-title': 'Am J Pathol'} / Am J Pathol / Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice by Rifai (1996)
  37. Butler M, Stecker K and Bennett CF, Histological localization of phosphorothioate oligodeoxynucleotides in normai rodent tissue. Nucleosides Nucleotides, in press.
  38. 10.1038/ki.1995.406 / Kidney Int / Renal uptake of an 18-mer phosphorothioate oligonucleotide by Oberbauer (1995)
  39. 10.1093/nar/19.20.5543 / Nucleic Acids Res / Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages by Shoji (1991)
  40. {'key': '10.1016/S0006-2952(97)00214-1_BIB40', 'first-page': '3474', 'article-title': 'Characterization of oligonucleotide transport into living cells', 'volume': '86', 'author': 'Loke', 'year': '1989'} / Characterization of oligonucleotide transport into living cells by Loke (1989)
  41. 10.1021/bi00069a022 / Biochemistry / Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells by Stein (1993)
  42. {'key': '10.1016/S0006-2952(97)00214-1_BIB42', 'first-page': '1023', 'article-title': 'Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides', 'volume': '41', 'author': 'Bennett', 'year': '1992', 'journal-title': 'Mol Pharmacol'} / Mol Pharmacol / Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides by Bennett (1992)
  43. {'key': '10.1016/S0006-2952(97)00214-1_BIB43', 'first-page': '843', 'article-title': 'Calcium dependent cellular uptake of a c-myc antisense oligonucleotide', 'volume': '40', 'author': 'Wu-Pong', 'year': '1994', 'journal-title': 'Cell Mol Biol'} / Cell Mol Biol / Calcium dependent cellular uptake of a c-myc antisense oligonucleotide by Wu-Pong (1994)
  44. 10.1111/1523-1747.ep12396876 / J Invest Dermatol / Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes by Nestle (1994)
  45. 10.1111/1523-1747.ep12371683 / J Invest Dermatol / Characteristics of oligonucleotide uptake in human keratinocyte cultures by Noonberg (1993)
  46. {'key': '10.1016/S0006-2952(97)00214-1_BIB46', 'first-page': '462', 'article-title': 'In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides', 'volume': '275', 'author': 'Crooke', 'year': '1995', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides by Crooke (1995)
  47. {'key': '10.1016/S0006-2952(97)00214-1_BIB47', 'first-page': '11762', 'article-title': 'Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides', 'volume': '91', 'author': 'Dean', 'year': '1994'} / Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides by Dean (1994)
  48. {'key': '10.1016/S0006-2952(97)00214-1_BIB48', 'first-page': '236', 'article-title': 'Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-α phosphorothioate oligodeoxynucleotide', 'volume': '50', 'author': 'Yazaki', 'year': '1996', 'journal-title': 'Mol Pharmacol'} / Mol Pharmacol / Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-α phosphorothioate oligodeoxynucleotide by Yazaki (1996)
  49. {'key': '10.1016/S0006-2952(97)00214-1_BIB49', 'first-page': '3499', 'article-title': 'Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-a expression', 'volume': '56', 'author': 'Dean', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-a expression by Dean (1996)
  50. 10.1038/nm0696-668 / Nature Med / Antitumor activity of a phosphorothioate oligodeoxynucleotide targeted against C-raf kinase by Monia (1995)
  51. 10.1172/JCI118679 / J Clin Invest / The role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice by Kumasaka (1996)
  52. 10.1038/nm0695-528 / Nature Med / A single-injection protein kinase A-directed antisense treatment to inhibit tumor growth by Nesterova (1995)
  53. 10.1038/nm0996-998 / Nature Med / Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-KB abrogates established experimental colitis in mice by Neurath (1996)
  54. 10.1172/JCI118681 / J Clin Invest / In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia by Noiri (1996)
  55. {'key': '10.1016/S0006-2952(97)00214-1_BIB55', 'first-page': '631', 'article-title': 'Experimental production and modulation of human cytotoxic dermatitis in human-murine chimeras', 'volume': '150', 'author': 'Christofidou-Solomidou', 'year': '1997', 'journal-title': 'Am J Pathol'} / Am J Pathol / Experimental production and modulation of human cytotoxic dermatitis in human-murine chimeras by Christofidou-Solomidou (1997)
  56. {'key': '10.1016/S0006-2952(97)00214-1_BIB56', 'first-page': '988', 'article-title': 'An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodiutn-induced colitis in mice', 'volume': '280', 'author': 'Bennett', 'year': '1997', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodiutn-induced colitis in mice by Bennett (1997)
  57. 10.1016/0167-4781(90)90031-V / Biochim Biophys Acta / Specific regulation of gene expression by antisense, sense and antigene nucleic acids by Helene (1990)
  58. 10.1016/S1054-3589(08)60492-5 / Adv Pharmacol / Regulation of endothelial cell adhesion molecule expression with antisense oligonucleotides by Bennett (1994)
  59. {'key': '10.1016/S0006-2952(97)00214-1_BIB59', 'series-title': 'Therapeutic Applications of Oligonucleotides', 'author': 'Crooke', 'year': '1995'} / Therapeutic Applications of Oligonucleotides by Crooke (1995)
  60. 10.1016/0006-2952(95)02220-1 / Biochem Pharmacol / Reduction of expression of the multidrug resistance protein, MRP, in human tumor cells by antisense phosphorothioate oligonucleotides by Stewart (1996)
  61. 10.1074/jbc.271.48.30398 / J Biol Chem / Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells by Condon (1996)
  62. 10.1089/ard.1995.5.23 / Antisense Res Dev / Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides by Giles (1995)
  63. 10.1016/S0021-9258(18)55250-9 / J Biol Chem / Antisense oligonucleotides inhibit intercellular adhesion molecule l expression by two distinct mechanisms by Chiang (1991)
  64. 10.1016/S0021-9258(19)85268-7 / J Biol Chem / Evaluation of 2′-modified oligonucleotides containing 2′deoxy gaps as antisense inhibitors of gene expression by Monia (1993)
  65. {'key': '10.1016/S0006-2952(97)00214-1_BIB65', 'first-page': '1300', 'article-title': 'Targeting RNA for degradation with a (2′-5′) oligoadenylate-antisense chimera', 'volume': '90', 'author': 'Torrence', 'year': '1993'} / Targeting RNA for degradation with a (2′-5′) oligoadenylate-antisense chimera by Torrence (1993)
  66. {'key': '10.1016/S0006-2952(97)00214-1_BIB66', 'first-page': '1936', 'article-title': 'Synthetic polynucleotides and the amino acid code', 'volume': '47', 'author': 'Lengyel', 'year': '1961'} / Synthetic polynucleotides and the amino acid code by Lengyel (1961)
  67. 10.1074/jbc.272.18.11994 / J Biol Chem / 2′-O-(2-Methoxy)ethyl modified anti-ICAM-1 oligonucleotides selectively increase the ICAM-1 mRNA Ievel and inhibit formation of the ICAM-1 translation initiation complex in HUVECs by Baker (1997)
  68. {'key': '10.1016/S0006-2952(97)00214-1_BIB68', 'first-page': '12840', 'article-title': 'Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides', 'volume': '93', 'author': 'Sierakowska', 'year': '1996'} / Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides by Sierakowska (1996)
  69. {'key': '10.1016/S0006-2952(97)00214-1_BIB69', 'first-page': '905', 'article-title': 'Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNA by antisense oligonucleotides', 'volume': '48', 'author': 'Hodges', 'year': '1995', 'journal-title': 'Mol Pharmacol'} / Mol Pharmacol / Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNA by antisense oligonucleotides by Hodges (1995)
  70. 10.4049/jimmunol.152.7.3530 / J Immunol / Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides by Bennett (1994)
  71. 10.1016/S0021-9258(19)88650-7 / J Biol Chem / Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides by Monia (1992)
  72. 10.1038/nm0696-668 / Nature Med / Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase by Monia (1996)
  73. {'key': '10.1016/S0006-2952(97)00214-1_BIB73', 'first-page': '15481', 'article-title': 'Sequence-Specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo', 'volume': '93', 'author': 'Monia', 'year': '1996'} / Sequence-Specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo by Monia (1996)
  74. 10.1016/S0021-9258(20)80622-X / J Biol Chem / Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells by Barbour (1993)
  75. {'key': '10.1016/S0006-2952(97)00214-1_BIB75', 'first-page': '7', 'article-title': 'Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells', 'volume': '32', 'author': 'Colige', 'year': '1993'} / Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells by Colige (1993)
  76. 10.1126/science.7684856 / Science / Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines by Wagner (1993)
  77. 10.1021/bi00194a002 / Biochemistry / Inhibition of human immunodeficiency virus type-l env expression by C-5 propyne oligonucleotides specific for rev-response element stem-loop V by Fenster (1994)
  78. 10.1074/jbc.270.13.7161 / J Biol Chem / Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides by Duff (1995)
  79. 10.1038/nbt0796-840 / Nature Biotech / Potent and selective inhibition of gene expression by an antisense heptanucleotide by Wagner (1996)
  80. 10.1007/BF02172105 / Perspect Drug Dis Des / Structural modifications toward improved antisense oligonucleotides by Matteucci (1996)
  81. 10.1021/jm00059a007 / J Med Chem / Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets by Kawasaki (1993)
  82. 10.1016/0092-8674(89)90036-6 / Cell / Antisense probing of the human U4/U6 snRNP with biotinylated 2′-OMe RNA oligonucleotides by Blencowe (1989)
  83. 10.1021/bi00081a031 / Biochemistry / Oligodeoxynucleotides containing 2′-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes by Lesnik (1993)
  84. {'key': '10.1016/S0006-2952(97)00214-1_BIB84', 'series-title': 'Antisense Research and Applications', 'first-page': '273', 'article-title': 'Heterocyclic base modifications in nucleic acids and their applications in antisense oligonucleotides', 'author': 'Sanghvi', 'year': '1993'} / Antisense Research and Applications / Heterocyclic base modifications in nucleic acids and their applications in antisense oligonucleotides by Sanghvi (1993)
  85. 10.1016/S0040-4039(00)76514-2 / Tetrahedron Lett / Remarkable enhancement of binding affinity of heterocyclemodified DNA to DNA and RNA. Synthesis, characterization and biophysical evaluation of N2-imidazolylpropylguanine and N2-imidazolylpropyl-2-aminoadenine modified oligonucleotides by Ramasamy (1994)
  86. 10.1021/bi960626v / Biochemistry / Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents by Kutyavin (1996)
  87. 10.1021/jo00063a014 / J Org Chem / Synthesis and binding properties of pyrimidine oligodeoxynucleoside analogs containing neutral phosphodiester replacements. The formacetal and 3′-thioformacetal internucleoside linkages by Jones (1993)
  88. 10.1021/ja00036a076 / J Am Chem Soc / Oligonucleosides: Synthesis of a novel methylhydroxylaminelinked nucleoside dimer and its incorporation into antisense sequences by Vasseur (1992)
  89. 10.1002/anie.199402261 / Angew Chem Int Ed / Amides as a new type of backbone modification in oligonucleotides by De Mesmaeker (1994)
  90. 10.1002/anie.199210081 / Angew Chem Int Edn / Peptide nucleic acids (PNAs)Unusual properties of nonionic oligonucleotide analogues by Meier (1992)
  91. 10.1038/365566a0 / Nature / PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules by Egholm (1993)
  92. {'key': '10.1016/S0006-2952(97)00214-1_BIB92', 'series-title': 'Oligonucleotides: Antisense Inhibitors of Gene Expression', 'first-page': '137', 'article-title': 'Control of gene expression by oligonucleotides covalently linked to intercalating agents and nucleic acid-cleaving reagents', 'author': 'Helene', 'year': '1989'} / Oligonucleotides: Antisense Inhibitors of Gene Expression / Control of gene expression by oligonucleotides covalently linked to intercalating agents and nucleic acid-cleaving reagents by Helene (1989)
  93. 10.1016/0003-9861(88)90652-2 / Arch Biochem Biophys / Inhibition of rabbit β-globin synthesis by complementary oligonucleotides: Identification of mRNA sites sensitive to inhibition by Goodchild (1988)
  94. {'key': '10.1016/S0006-2952(97)00214-1_BIB94', 'first-page': '13', 'article-title': 'Walking along human c-myc mRNA with antisense oligodeoxynucleotides: Maximum efficacy at the 5′ cap region', 'volume': '6', 'author': 'Bacon', 'year': '1991', 'journal-title': 'Oncogene Res'} / Oncogene Res / Walking along human c-myc mRNA with antisense oligodeoxynucleotides: Maximum efficacy at the 5′ cap region by Bacon (1991)
  95. 10.1074/jbc.272.1.626 / J Biol Chem / Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity by Lima (1997)
  96. 10.1021/bi00163a013 / Biochemistry / Implication of RNA structure on antisense oligonucleotide hybridization kinetics by Lima (1992)
  97. {'key': '10.1016/S0006-2952(97)00214-1_BIB97', 'first-page': '223', 'article-title': 'Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: Implications for antisense technology', 'volume': '41', 'author': 'Gao', 'year': '1992', 'journal-title': 'Mol Pharmacol'} / Mol Pharmacol / Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: Implications for antisense technology by Gao (1992)
  98. {'key': '10.1016/S0006-2952(97)00214-1_BIB98', 'first-page': '5957', 'article-title': 'Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides', 'volume': '91', 'author': 'Perez', 'year': '1994'} / Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides by Perez (1994)
  99. 10.1074/jbc.270.6.2620 / J Biol Chem / Phosphorothioate oligodeoxynucleotides bind to basie fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix by Guvakova (1995)
  100. 10.1093/nar/22.15.3202 / Nucleic Acids Res / Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides by Bennett (1994)
  101. {'key': '10.1016/S0006-2952(97)00214-1_BIB101', 'first-page': '4051', 'article-title': 'The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism', 'volume': '92', 'author': 'Burgess', 'year': '1995'} / The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism by Burgess (1995)
  102. 10.1038/374546a0 / Nature / CpG motifs in bacterial DNA trigger direct B-cell activation by Krieg (1995)
  103. 10.1038/355564a0 / Nature / Selection of single-stranded DNA molecules that bind and inhibit human thrombin by Bock (1992)
  104. 10.1038/355850a0 / Nature / Selection in vitro of singlestranded DNA molecules that fold into specific ligandbinding structures by Ellington (1992)
  105. 10.1016/S0960-9822(00)00093-2 / Curr Biol / Aptamers achieve the desired recognition by Ellington (1994)
  106. 10.1093/nar/23.21.4239 / Nucleic Acids Res / Binding of phosphorothioate oligodeoxynucleotides to basie fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent by Benimetskaya (1995)
  107. 10.1016/0167-7799(96)20006-X / Trends Biotechnol / Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity by Stein (1996)
  108. 10.1093/nar/23.7.1146 / Nucleic Acids Res / Sequence context of antisense RelA/NF-κB phosphorothioates determines specificity by Maltese (1995)
  109. 10.1016/S0959-440X(05)80106-X / Curr Opin Struct Biol / Guanine quartets by Williamson (1993)
  110. 10.4049/jimmunol.157.5.1840 / J Immunol / Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA by Ballas (1996)
  111. {'key': '10.1016/S0006-2952(97)00214-1_BIB111', 'first-page': '421', 'article-title': 'Immune stimulation-A class effect of phosphorothioate oligonucleotides in rodents', 'volume': '12', 'author': 'Monteith', 'year': '1997', 'journal-title': 'Anticancer Drug Des'} / Anticancer Drug Des / Immune stimulation-A class effect of phosphorothioate oligonucleotides in rodents by Monteith (1997)
  112. Levin AA, Monteith DK, Leeds JM, Nicklin PL, Geary RS, Butler M, Templin MV and Henry SP, Toxicity of oligodeoxynucleotide therapeutic agents. In: Antisense Research and Applications (Ed. Crooke ST). Springer, Heidelberg, in press. (10.1007/978-3-642-58785-6_5)
  113. 10.1111/j.1749-6632.1990.tb17838.x / Ann NY Acad Sci / Large-scale economic synthesis of antisense phosphorothioate analogues of DNA for preclinical investigations by Geiser (1990)
  114. 10.1016/0006-2952(95)00160-2 / Biochem Pharmacol / Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration by Agrawal (1995)
  115. {'key': '10.1016/S0006-2952(97)00214-1_BIB115', 'first-page': '6553', 'article-title': 'Cholesteryl-conjugated oligonucleotides: Synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture', 'volume': '86', 'author': 'Letsinger', 'year': '1989'} / Cholesteryl-conjugated oligonucleotides: Synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture by Letsinger (1989)
  116. {'key': '10.1016/S0006-2952(97)00214-1_BIB116', 'first-page': '808', 'article-title': 'Inhibition of expression of the multidrug resistance-associated P-glycoprotein by phosphorothioate and 5′-cholesterol-conjugated phosphorothioate antisense oligonucleotides', 'volume': '50', 'author': 'Alahari', 'year': '1996', 'journal-title': 'Mol Pharmacol'} / Mol Pharmacol / Inhibition of expression of the multidrug resistance-associated P-glycoprotein by phosphorothioate and 5′-cholesterol-conjugated phosphorothioate antisense oligonucleotides by Alahari (1996)
  117. 10.1016/0168-3659(96)01362-4 / J Control Rel / Pharmacokinetics in mice of a [3H]labeled phosphorothioate oligonucleotide formulated in the presence and absence of a cationic lipid by Bennett (1996)
  118. 10.1002/elps.11501601256 / Electrophoresis / DNA fingerprinting by hybridization to oligonucleotide arrays by Southern (1995)
  119. {'key': '10.1016/S0006-2952(97)00214-1_BIB119', 'first-page': '383', 'article-title': 'Antisense oligonucleotide inhibitors for the treatment of cancer: l) Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides', 'volume': '12', 'author': 'Geary', 'year': '1997', 'journal-title': 'Anticancer Drug Des'} / Anticancer Drug Des / Antisense oligonucleotide inhibitors for the treatment of cancer: l) Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides by Geary (1997)
  120. 10.1016/0006-2952(95)02177-9 / Biochem Pharmacol / Effect of different chemically modified oligodeoxynucleotides on immune stimulation by Zhao (1996)
  121. Boggs RT, McGraw K, Condon T, Flournoy S, Villiet P, Bennett CF and Monia BP, Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev, in press. (10.1089/oli.1.1997.7.461)
  122. 10.1089/ard.1995.5.131 / Antisense Res Dev / Characterization of binding sites, extent of binding, and drug interactions of oligonucleotides with albumin by Kumar (1995)
  123. 10.1080/15257779508014667 / Nucleosides Nucleotides / Preparation of oligomeric 2′-deoxy5-fluorouridylate of defined length and backbone composition: A novel pro-drug form of the potent anti-cancer drug 2′-deoxy-5-fluorouridylate by Gmeiner (1995)
Dates
Type When
Created 23 years, 1 month ago (July 25, 2002, 10:51 a.m.)
Deposited 2 years, 4 months ago (April 9, 2023, 7:53 a.m.)
Indexed 1 month ago (Aug. 2, 2025, 1:07 a.m.)
Issued 27 years, 8 months ago (Jan. 1, 1998)
Published 27 years, 8 months ago (Jan. 1, 1998)
Published Print 27 years, 8 months ago (Jan. 1, 1998)
Funders 0

None

@article{Bennett_1998, title={Antisense oligonucleotides: Is the glass half full or half empty?}, volume={55}, ISSN={0006-2952}, url={http://dx.doi.org/10.1016/s0006-2952(97)00214-1}, DOI={10.1016/s0006-2952(97)00214-1}, number={1}, journal={Biochemical Pharmacology}, publisher={Elsevier BV}, author={Bennett, C.Frank}, year={1998}, month=jan, pages={9–19} }